Search by Drug Name or NDC

    NDC 70954-0135-20 DAPSONE 25 mg/1 Details

    DAPSONE 25 mg/1

    DAPSONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ANI Pharmaceuticals, Inc.. The primary component is DAPSONE.

    Product Information

    NDC 70954-0135
    Product ID 70954-135_1efed13c-1c45-48e7-ad3d-c2355f67e6a4
    Associated GPIs 16300010000310
    GCN Sequence Number 009623
    GCN Sequence Number Description dapsone TABLET 25 MG ORAL
    HIC3 W4P
    HIC3 Description ANTILEPROTICS
    GCN 43361
    HICL Sequence Number 004177
    HICL Sequence Number Description DAPSONE
    Brand/Generic Generic
    Proprietary Name DAPSONE
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dapsone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 25
    Active Ingredient Units mg/1
    Substance Name DAPSONE
    Labeler Name ANI Pharmaceuticals, Inc.
    Pharmaceutical Class Sulfone [EPC], Sulfones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206505
    Listing Certified Through 2024-12-31

    Package

    NDC 70954-0135-20 (70954013520)

    NDC Package Code 70954-135-20
    Billing NDC 70954013520
    Package 100 TABLET in 1 BOTTLE (70954-135-20)
    Marketing Start Date 2018-01-15
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.52608
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DAPSONE 25 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis